Capadenoson

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameCapadenoson
Drug Alias NameCapadenosonum卡帕迪松卡帕诺生BAY-68-4986
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor agonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsAngina, StableAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSlovakiaPoland +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsAngina, StableAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A